Depending on your requirements, from bringing in novel cannabinoid-related compounds or conducting late-phase clinical studies, we will be able to provide a turn-key solution for your needs.
The MCRC Medical Writing team works collaboratively with involvement from therapeutic area Key Opinion Leaders, Clinical Scientists, Biostatistician, Medical and Pharmacokinetic experts throughout the Clinical Trial Design and Protocol Development process. MCRC’s extensive knowledge of current treatment practices ensures that our protocols are practical and scientifically evaluated to generate quality data, endpoints and trial outcomes.
The Clinical Trial Protocol is developed in compliance with Guideline for Good Clinical Practice ICH E6 (R2).
The Clinical Trial Report is prepared according to the Guideline for Structure and Content of Clinical Study Reports ICH E3.